<ul>
<li>检查团队将在阿联酋入境点驻守，以加快药品运输清关</li>
</ul>
<p><strong>迪拜，阿联酋：</strong> 阿联酋药品管理局（EDE）宣布成立一个由 16 个战略合作伙伴组成的工作组，涉及阿联酋的药品和物流供应链，包括药品制造商、医疗仓库、储存设施和物流提供商。</p>
<p>该工作组旨在增强国家药品供应系统的韧性，并加强各主管部门之间的协调，以确保药品和医疗产品在国内的持续供应，同时支持医疗行业的准备工作。</p>
<p>在阿联酋药品管理局主持的会议上，工作组讨论了协调努力和制定主动计划，以确保药品和医疗产品在供应链各个阶段的顺畅流动，从制造、储存到本地市场的分销，使药品行业能够适应变化并确保供应的连续性。</p>
<p>官员们还审查了当前的药品库存水平，制造商和仓库的代表确认国内市场药品和医疗产品的供应充足。</p>
<p>与药品供应流动相关的操作信息和技术专长也进行了交流，以支持主动规划并提高国内药品库存管理的效率。</p>
<p>该工作组还将制定信息和操作数据共享机制，支持主动规划和风险管理，增强参与实体之间的协调，并加强在操作和监管层面的决策，同时提高库存管理效率，确保重要医疗产品的持续供应。</p>
<p>阿联酋药品管理局局长法蒂玛·阿尔卡比（H.E. Dr. Fatima Al Kaabi）表示，增强药品供应链的韧性是阿联酋药品安全框架的关键支柱。</p>
<p>阿尔卡比补充道：“药品管理局将继续完善其监管体系，并加强与医疗和物流行业合作伙伴的合作，以确保药品和医疗产品的可持续供应，符合最高的安全、质量和有效性标准。”</p>
<p>她指出，工作组的成立证明了 EDE 与政府和私营部门合作伙伴密切合作的努力。“这一步将有助于增强药品行业的准备能力，提高医疗系统对影响供应链的任何发展做出高效响应的能力，同时确保医疗服务的持续性。”</p>
<p>与此同时，阿联酋药品管理局局长顾问、工作组负责人玛丽亚姆·阿尔马兹鲁伊博士表示，团队将致力于在相关实体之间建立更有效的协调和沟通渠道，以便交换与药品和医疗产品流动相关的操作数据和技术专长，同时支持主动规划和风险管理。</p>
<p>阿尔马兹鲁伊补充说，提高与药品供应链相关的物流操作效率是团队的关键优先事项之一。</p>
<p>她表示：“从加快药品运输入境程序到便利医疗产品通过国家入境口岸的流动，我们致力于确保供应流畅，并在符合最高质量和安全标准的情况下，确保本地市场药品的持续供应。”</p>
<p>阿联酋药品管理局澄清，将提供必要的监管便利，以实施商定的措施，包括将进口许可证的有效期延长两个月。</p>
<p>它还补充说，其检查团队将在卡车入境点驻守，以加快医疗产品和用于其制造的原材料的海关清关和检查程序，并与相关部门协调。</p>
<p>该机构表示，必要时也可以在公司仓库内提供货物清关服务，以加快操作程序并提高物流效率，同时确保阿联酋医疗产品的最高安全和质量标准。</p>
<p>该工作组倡议是该机构加强与医疗和物流行业利益相关者的机构合作伙伴关系的努力的一部分，支持药品供应的可持续性，增强国家的药品安全，并确保药品和医疗产品的持续供应，以满足患者和医疗机构的需求。</p>
<p>请将您的新闻稿发送至 pressrelease.zawya@lseg.com</p>
<p>免责声明：本新闻稿的内容由外部第三方提供。本网站不对该外部内容负责，也不控制该内容。该内容按 “现状” 和 “可用” 基础提供，未经过任何编辑。本网站及我们的附属机构不保证该新闻稿中表达的观点或意见的准确性。</p>
<p>本新闻稿仅供信息参考。内容不提供税务、法律或投资建议，也不对任何特定证券、投资组合或投资策略的适用性、价值或盈利能力发表意见。本网站及我们的附属机构对内容中的任何错误或不准确之处，或因您依赖该内容而采取的任何行动不承担任何责任。您明确同意，您对本文中信息的使用风险自负。</p>
<p>在适用法律允许的最大范围内，本网站及其母公司、子公司、关联公司以及各自的股东、董事、高级职员、员工、代理人、广告商、内容提供者和许可方对您不承担任何直接、间接、后果性、特殊、附带、惩罚性或示范性损害赔偿责任，包括但不限于利润损失、储蓄损失和收入损失，无论是基于过失、侵权、合同还是任何其他责任理论，即使各方已被告知可能性或可以预见到任何此类损害。</p>

<p>阿联酋药品机构（EDE）与 16 个合作伙伴组建了一个国家工作组，以增强阿联酋的药品供应链。该工作组旨在改善利益相关者之间的协调，确保药品和医疗产品的可用性。它将重点关注主动规划、风险管理和高效的物流操作。EDE 将促进监管措施，包括延长进口许可证的有效期和加快药品运输的海关清关。这项倡议是 EDE 致力于加强药品安全和支持阿联酋医疗行业韧性的承诺的一部分</p>

<ul>
<li>Inspection teams to be present at UAE entry points to speed up pharmaceutical shipment clearance</li>
</ul>
<div class="lb-trans"><ul>
<li>检查团队将在阿联酋入境点驻守，以加快药品运输清关</li>
</ul>
</div><p><strong>Dubai, UAE:</strong> The Emirates Drug Establishment (EDE) has announced the setting up of a task force comprising 16 strategic partners involved in pharmaceutical and logistics supply chains across the UAE, including drug manufacturers, medical warehouses, storage facilities and logistics providers.</p>
<div class="lb-trans"><p><strong>迪拜，阿联酋：</strong> 阿联酋药品管理局（EDE）宣布成立一个由 16 个战略合作伙伴组成的工作组，涉及阿联酋的药品和物流供应链，包括药品制造商、医疗仓库、储存设施和物流提供商。</p>
</div><p>The task force aims to strengthen the resilience of the country’s pharmaceutical supply system and enhance coordination among competent authorities to ensure the continued availability of medicines and medical products in the country while supporting the readiness of the healthcare sector.</p>
<div class="lb-trans"><p>该工作组旨在增强国家药品供应系统的韧性，并加强各主管部门之间的协调，以确保药品和医疗产品在国内的持续供应，同时支持医疗行业的准备工作。</p>
</div><p>During its meeting, chaired by the Emirates Drug Establishment, the task force discussed coordinating efforts and developing proactive plans to ensure the smooth flow of medicines and medical products across all stages of the supply chain, from manufacturing and storage to distribution in the local market, enabling the pharmaceutical sector to adapt to changes and ensure continuity of supply.</p>
<div class="lb-trans"><p>在阿联酋药品管理局主持的会议上，工作组讨论了协调努力和制定主动计划，以确保药品和医疗产品在供应链各个阶段的顺畅流动，从制造、储存到本地市场的分销，使药品行业能够适应变化并确保供应的连续性。</p>
</div><p>Officials also reviewed current pharmaceutical stock levels, with representatives from manufacturers and warehouses confirming sufficient supplies of medicines and medical products in the domestic market.</p>
<div class="lb-trans"><p>官员们还审查了当前的药品库存水平，制造商和仓库的代表确认国内市场药品和医疗产品的供应充足。</p>
</div><p>Operational information and technical expertise related to pharmaceutical supply movements were also exchanged, supporting proactive planning and enhancing the efficiency of drug inventory management in the country.</p>
<div class="lb-trans"><p>与药品供应流动相关的操作信息和技术专长也进行了交流，以支持主动规划并提高国内药品库存管理的效率。</p>
</div><p>The task force will also develop mechanisms for sharing information and operational data related to pharmaceutical supplies, supporting proactive planning and risk management, enhancing coordination among participating entities, and strengthening decision-making at both operational and regulatory levels, while also improving inventory management efficiency and ensuring the continued availability of vital medical products.</p>
<div class="lb-trans"><p>该工作组还将制定信息和操作数据共享机制，支持主动规划和风险管理，增强参与实体之间的协调，并加强在操作和监管层面的决策，同时提高库存管理效率，确保重要医疗产品的持续供应。</p>
</div><p>H.E. Dr. Fatima Al Kaabi, Director General of the Emirates Drug Establishment, said that strengthening the resilience of pharmaceutical supply chains is a key pillar of the UAE’s drug security framework.</p>
<div class="lb-trans"><p>阿联酋药品管理局局长法蒂玛·阿尔卡比（H.E. Dr. Fatima Al Kaabi）表示，增强药品供应链的韧性是阿联酋药品安全框架的关键支柱。</p>
</div><p>“The Establishment will continue to develop its regulatory systems and strengthen cooperation with partners across the healthcare and logistics sectors to ensure the sustainable availability of medicines and medical products in line with the highest standards of safety, quality and effectiveness,” Al Kaabi added.</p>
<div class="lb-trans"><p>阿尔卡比补充道：“药品管理局将继续完善其监管体系，并加强与医疗和物流行业合作伙伴的合作，以确保药品和医疗产品的可持续供应，符合最高的安全、质量和有效性标准。”</p>
</div><p>Her Excellency noted the formation of the task force is a testament to how EDE is working closely with both government and private sector partners. “This step will help strengthen the pharmaceutical sector’s preparedness and improve the healthcare system’s ability to respond efficiently to any developments affecting supply chains while ensuring that healthcare services continue without disruption.”</p>
<div class="lb-trans"><p>她指出，工作组的成立证明了 EDE 与政府和私营部门合作伙伴密切合作的努力。“这一步将有助于增强药品行业的准备能力，提高医疗系统对影响供应链的任何发展做出高效响应的能力，同时确保医疗服务的持续性。”</p>
</div><p>Meanwhile, Dr Mariam Al Mazrouei, adviser to the Director General of the Emirates Drug Establishment and head of the task force, said the team will work to develop more effective coordination and communication channels among relevant entities, enabling the exchange of operational data and technical expertise related to the movement of medicines and medical products, while supporting proactive planning and risk management.</p>
<div class="lb-trans"><p>与此同时，阿联酋药品管理局局长顾问、工作组负责人玛丽亚姆·阿尔马兹鲁伊博士表示，团队将致力于在相关实体之间建立更有效的协调和沟通渠道，以便交换与药品和医疗产品流动相关的操作数据和技术专长，同时支持主动规划和风险管理。</p>
</div><p>Al Mazrouei added that enhancing the efficiency of logistics operations linked to pharmaceutical supply chains is one of the team’s key priorities.</p>
<div class="lb-trans"><p>阿尔马兹鲁伊补充说，提高与药品供应链相关的物流操作效率是团队的关键优先事项之一。</p>
</div><p>“From accelerating procedures for the entry of pharmaceutical shipments to facilitating the movement of medical products through the country’s ports of entry, we are committed to ensuring smooth supply flows and the continued availability of medicines in the local market in line with the highest standards of quality and safety,” she said.</p>
<div class="lb-trans"><p>她表示：“从加快药品运输入境程序到便利医疗产品通过国家入境口岸的流动，我们致力于确保供应流畅，并在符合最高质量和安全标准的情况下，确保本地市场药品的持续供应。”</p>
</div><p>The Emirates Drug Establishment clarified it will provide the necessary regulatory facilitation to implement the agreed measures, including extending the validity of import permits by an additional two months.</p>
<div class="lb-trans"><p>阿联酋药品管理局澄清，将提供必要的监管便利，以实施商定的措施，包括将进口许可证的有效期延长两个月。</p>
</div><p>It added that its inspection teams will be present at truck entry points to speed up customs clearance and inspection procedures for medical products and raw materials used in their manufacture, in coordination with relevant authorities.</p>
<div class="lb-trans"><p>它还补充说，其检查团队将在卡车入境点驻守，以加快医疗产品和用于其制造的原材料的海关清关和检查程序，并与相关部门协调。</p>
</div><p>The Establishment stated that shipment clearance services may also be provided within company warehouses when needed to accelerate operational procedures and improve logistics efficiency, while ensuring the highest safety and quality standards for medical products in the UAE.</p>
<div class="lb-trans"><p>该机构表示，必要时也可以在公司仓库内提供货物清关服务，以加快操作程序并提高物流效率，同时确保阿联酋医疗产品的最高安全和质量标准。</p>
</div><p>The task force initiative falls under the establishment’s efforts to strengthen institutional partnerships with stakeholders across the healthcare and logistics sectors, supporting the sustainability of pharmaceutical supplies, enhancing drug security in the country, and ensuring the continued availability of medicines and medical products to meet the needs of patients and healthcare facilities.</p>
<div class="lb-trans"><p>该工作组倡议是该机构加强与医疗和物流行业利益相关者的机构合作伙伴关系的努力的一部分，支持药品供应的可持续性，增强国家的药品安全，并确保药品和医疗产品的持续供应，以满足患者和医疗机构的需求。</p>
</div><p>Send us your press releases to pressrelease.zawya@lseg.com</p>
<div class="lb-trans"><p>请将您的新闻稿发送至 pressrelease.zawya@lseg.com</p>
</div><p>Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.</p>
<div class="lb-trans"><p>免责声明：本新闻稿的内容由外部第三方提供。本网站不对该外部内容负责，也不控制该内容。该内容按 “现状” 和 “可用” 基础提供，未经过任何编辑。本网站及我们的附属机构不保证该新闻稿中表达的观点或意见的准确性。</p>
</div><p>The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.</p>
<div class="lb-trans"><p>本新闻稿仅供信息参考。内容不提供税务、法律或投资建议，也不对任何特定证券、投资组合或投资策略的适用性、价值或盈利能力发表意见。本网站及我们的附属机构对内容中的任何错误或不准确之处，或因您依赖该内容而采取的任何行动不承担任何责任。您明确同意，您对本文中信息的使用风险自负。</p>
</div><p>To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.</p>
<div class="lb-trans"><p>在适用法律允许的最大范围内，本网站及其母公司、子公司、关联公司以及各自的股东、董事、高级职员、员工、代理人、广告商、内容提供者和许可方对您不承担任何直接、间接、后果性、特殊、附带、惩罚性或示范性损害赔偿责任，包括但不限于利润损失、储蓄损失和收入损失，无论是基于过失、侵权、合同还是任何其他责任理论，即使各方已被告知可能性或可以预见到任何此类损害。</p>
</div>

ZAWYA-PRESSR：阿联酋药品机构成立国家工作组，支持可持续的药品供应链